What are the major opportunities in the Live Attenuated Vaccines market? What are the strategies for the Live Attenuated Vaccines market?

For detailed insights on the major opportunities and strategies in the Live Attenuated Vaccines market, Read More

How does the Live Attenuated Vaccines market relate to the overall economy and other similar markets?

For detailed insights on Live Attenuated Vaccines's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Live Attenuated Vaccines market growth? SWOT analysis of the Live Attenuated Vaccines market.

For detailed insights on the key dynamics influencing the Live Attenuated Vaccines market growth and SWOT analysis of the Live Attenuated Vaccines industry, Read More

Global Live Attenuated Vaccines Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Live Attenuated Vaccines Global Market Report 2025

Name: Live Attenuated Vaccines Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Vaccine Type (Monovalent, Multivalent), By Route Of Administration (Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated), By Indication (Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Live Attenuated Vaccines Market?

Live attenuated vaccines are biological formulations that use a weakened version of a virus or bacterium, engineered in the lab to prevent it from causing illness in healthy individuals. By closely simulating a natural infection, these vaccines trigger a robust and long-lasting immune response, often requiring only one or two doses for effective protection against infectious diseases.

The main types of live attenuated vaccines include monovalent and Multivalent. Monovalent refers to a substance, such as a vaccine or ion, that is effective against or involves only one specific antigen, strain, or type. It is administered through various routes of administration, such as intramuscular, subcutaneous, oral attenuated, and intranasal attenuated, for several indications, including Influenza, measles, mumps, and rubella (MMR), polio, chickenpox, shingles, rotavirus, and others. It is distributed through various distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and is used by various end-users, including hospitals, clinics, diagnostic centers, research institutes, and others.

Live Attenuated Vaccines Market Size and growth rate 2025 to 2029: Graph

What Is The Live Attenuated Vaccines Market Size 2025 And Growth Rate?

The live attenuated vaccines market size has grown rapidly in recent years. It will grow from $23.58 billion in 2024 to $25.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising global immunization coverage, increasing public health spending, growing awareness of disease prevention, rising demand for pediatric vaccines, and expansion of vaccination programs.

What Is The Live Attenuated Vaccines Market Growth Forecast?

The live attenuated vaccines market size is expected to see strong growth in the next few years. It will grow to $37.56 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising focus on preventive healthcare, increasing adoption in low- and middle-income countries, growing support for outbreak preparedness, increasing travel-related vaccination needs, and expansion of government-funded immunization initiatives. Major trends in the forecast period include advancements in vaccine delivery systems, innovations in genetic attenuation techniques, investment in research and development, development of thermostable formulations, and innovation of digital technologies in immunization programs.

Book your 30 minutes free consultation with our research experts

How Is The Live Attenuated Vaccines Market Segmented?

The live attenuated vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Route Of Administration: Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated

3) By Indication: Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users

Subsegments:

1) By Monovalent: Single-Dose Vaccines, Multiple-Dose Vaccines

2) By Multivalent: Bivalent Vaccines, Trivalent Vaccines, Quadrivalent Vaccines, Other Multivalent Vaccines

What Is Driving The Live Attenuated Vaccines Market? The Increasing Prevalence Of Infectious Diseases Is Fueling The Growth Of The Market Due To Rising Global Incidence And Demand For Effective Long-Term Immunization

The increasing prevalence of infectious diseases is expected to propel the growth of the live attenuated vaccines market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person, animal, or environment to another. Rising global travel accelerates the spread of infectious diseases by allowing pathogens to cross borders faster than containment efforts. Live attenuated vaccines help prevent infectious diseases by stimulating a strong immune response with weakened pathogens, ensuring long-term immunity and reducing disease spread. For instance, in March 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2023, an estimated 10.8 million people fell ill with TB worldwide, including 6.0 million men, 3.6 million women, and 1.3 million children. Therefore, the increasing prevalence of infectious diseases is driving the growth of the live attenuated vaccines market.

Who Are The Major Players In The Global Live Attenuated Vaccines Market?

Major companies operating in the live attenuated vaccines market are Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, CSL Limited, GC Biopharma, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Valneva SE, Southern Research, BioFarma, Bharat Biotech International Limited, Meissa Vaccines Inc., BioDiem Ltd., Bio-Med Limited, Naobios, Lakshmi Pharmaceuticals

What Are The Key Trends Of The Global Live Attenuated Vaccines Market? Advancements In Single-Dose Live Attenuated Vaccines For Enhanced Immunization

Major companies operating in the live attenuated vaccines market are focusing on developing advanced products such as single-dose vaccines to enhance immunization efficiency and improve patient compliance. Single-dose vaccines provide lasting immunity with a single shot, eliminating the need for multiple doses. This simplifies vaccination for patients and healthcare providers, enhancing convenience and accessibility. For instance, in November 2023, Valneva SE, a France-based biotech company that manufactures vaccines for infectious diseases, announced the launch of IXCHIQ, which received approval from the U.S. Food and Drug Administration (FDA), a US-based health agency. It is the world’s first live-attenuated chikungunya vaccine indicated for adults aged 18 and older. This approval is significant because IXCHIQ is the world's first licensed vaccine for chikungunya, addressing an unmet medical need for protection against this mosquito-borne viral disease, which can cause severe fever, joint and muscle pain, and other symptoms

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Live Attenuated Vaccines Market? Bavarian Nordic Acquired Emergent BioSolutions' Travel Health Business

In May 2023, Bavarian Nordic A/S, a Denmark-based biotechnology company, acquired a travel health business from Emergent BioSolutions Inc. for approximately $380 million. With this acquisition, Bavarian Nordic aims to expand its vaccine portfolio, including VIVOTIF for typhoid fever, VAXCHORA for cholera, and the chikungunya vaccine candidate CHIKV VLP, along with its manufacturing and development facilities in Switzerland and California. Emergent BioSolutions Inc. is a US-based biopharmaceutical company that manufactures live attenuated vaccines.

What Is The Regional Outlook For The Global Live Attenuated Vaccines Market?

North America was the largest region in the live attenuated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the live attenuated vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Live Attenuated Vaccines Market?

The live attenuated vaccine market consists of sales of viral live attenuated vaccines, bacterial live attenuated vaccines, and intranasal live attenuated vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Live Attenuated Vaccines Industry?

The live attenuated vaccines market research report is one of a series of new reports from The Business Research Company that provides live attenuated vaccines market statistics, including the live attenuated vaccines industry global market size, regional shares, competitors with the live attenuated vaccines market share, detailed live attenuated vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the live attenuated vaccines industry. These live attenuated vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Live Attenuated Vaccines Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$25.95 billion
Revenue Forecast In 2034	$37.56 billion
Growth Rate	CAGR of 9.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The live attenuated vaccines market covered in this report is segmented – 1) By Vaccine Type: Monovalent, Multivalent 2) By Route Of Administration: Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated 3) By Indication: Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 5) By End-User: Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users Subsegments: 1) By Monovalent: Single-Dose Vaccines, Multiple-Dose Vaccines 2) By Multivalent: Bivalent Vaccines, Trivalent Vaccines, Quadrivalent Vaccines, Other Multivalent Vaccines
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, CSL Limited, GC Biopharma, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Valneva SE, Southern Research, BioFarma, Bharat Biotech International Limited, Meissa Vaccines Inc., BioDiem Ltd., Bio-Med Limited, Naobios, Lakshmi Pharmaceuticals
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Live Attenuated Vaccines Market Characteristics

3. Live Attenuated Vaccines Market Trends And Strategies

4. Live Attenuated Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Live Attenuated Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Live Attenuated Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Live Attenuated Vaccines Market Growth Rate Analysis

5.4. Global Live Attenuated Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Live Attenuated Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Live Attenuated Vaccines Total Addressable Market (TAM)

6. Live Attenuated Vaccines Market Segmentation

6.1. Global Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monovalent

Multivalent

6.2. Global Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intramuscular

Subcutaneous

Oral Attenuated

Intranasal Attenuated

6.3. Global Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Influenza

Measles, Mumps And Rubella (MMR)

Polio

Chickenpox

Shingles

Rotavirus

Other Indications

6.4. Global Live Attenuated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.5. Global Live Attenuated Vaccines Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Diagnostic Centers

Research Institute

Other End-Users

6.6. Global Live Attenuated Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Dose Vaccines

Multiple-Dose Vaccines

6.7. Global Live Attenuated Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bivalent Vaccines

Trivalent Vaccines

Quadrivalent Vaccines

Other Multivalent Vaccines

7. Live Attenuated Vaccines Market Regional And Country Analysis

7.1. Global Live Attenuated Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Live Attenuated Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Live Attenuated Vaccines Market

8.1. Asia-Pacific Live Attenuated Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Live Attenuated Vaccines Market

9.1. China Live Attenuated Vaccines Market Overview

9.2. China Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Live Attenuated Vaccines Market

10.1. India Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Live Attenuated Vaccines Market

11.1. Japan Live Attenuated Vaccines Market Overview

11.2. Japan Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Live Attenuated Vaccines Market

12.1. Australia Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Live Attenuated Vaccines Market

13.1. Indonesia Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Live Attenuated Vaccines Market

14.1. South Korea Live Attenuated Vaccines Market Overview

14.2. South Korea Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Live Attenuated Vaccines Market

15.1. Western Europe Live Attenuated Vaccines Market Overview

15.2. Western Europe Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Live Attenuated Vaccines Market

16.1. UK Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Live Attenuated Vaccines Market

17.1. Germany Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Live Attenuated Vaccines Market

18.1. France Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Live Attenuated Vaccines Market

19.1. Italy Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Live Attenuated Vaccines Market

20.1. Spain Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Live Attenuated Vaccines Market

21.1. Eastern Europe Live Attenuated Vaccines Market Overview

21.2. Eastern Europe Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Live Attenuated Vaccines Market

22.1. Russia Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Live Attenuated Vaccines Market

23.1. North America Live Attenuated Vaccines Market Overview

23.2. North America Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Live Attenuated Vaccines Market

24.1. USA Live Attenuated Vaccines Market Overview

24.2. USA Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Live Attenuated Vaccines Market

25.1. Canada Live Attenuated Vaccines Market Overview

25.2. Canada Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Live Attenuated Vaccines Market

26.1. South America Live Attenuated Vaccines Market Overview

26.2. South America Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Live Attenuated Vaccines Market

27.1. Brazil Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Live Attenuated Vaccines Market

28.1. Middle East Live Attenuated Vaccines Market Overview

28.2. Middle East Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Live Attenuated Vaccines Market

29.1. Africa Live Attenuated Vaccines Market Overview

29.2. Africa Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Live Attenuated Vaccines Market Competitive Landscape And Company Profiles

30.1. Live Attenuated Vaccines Market Competitive Landscape

30.2. Live Attenuated Vaccines Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Live Attenuated Vaccines Market Other Major And Innovative Companies

31.1. Takeda Pharmaceutical Company Limited

31.2. Boehringer Ingelheim International GmbH

31.3. CSL Limited

31.4. GC Biopharma

31.5. Serum Institute of India Pvt. Ltd.

31.6. Bavarian Nordic

31.7. Valneva SE

31.8. Southern Research

31.9. BioFarma

31.10. Bharat Biotech International Limited

31.11. Meissa Vaccines Inc.

31.12. BioDiem Ltd.

31.13. Bio-Med Limited

31.14. Lakshmi Pharmaceuticals

31.15. Biosynth AG

32. Global Live Attenuated Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Live Attenuated Vaccines Market

34. Recent Developments In The Live Attenuated Vaccines Market

35. Live Attenuated Vaccines Market High Potential Countries, Segments and Strategies

35.1 Live Attenuated Vaccines Market In 2029 - Countries Offering Most New Opportunities

35.2 Live Attenuated Vaccines Market In 2029 - Segments Offering Most New Opportunities

35.3 Live Attenuated Vaccines Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Live Attenuated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Live Attenuated Vaccines Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Live Attenuated Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Live Attenuated Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Live Attenuated Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Live Attenuated Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Merck & Co. Inc. Financial Performance

Table 79: Sanofi SA Financial Performance

Table 80: AstraZeneca plc Financial Performance

Table 81: Abbott Laboratories Financial Performance

Table 82: GlaxoSmithKline plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Live Attenuated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Live Attenuated Vaccines Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Live Attenuated Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Live Attenuated Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Live Attenuated Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Live Attenuated Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Merck & Co. Inc. Financial Performance

Figure 79: Sanofi SA Financial Performance

Figure 80: AstraZeneca plc Financial Performance

Figure 81: Abbott Laboratories Financial Performance

Figure 82: GlaxoSmithKline plc Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Veterinary Vaccines Global Market Report 2025 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Othe...

Vaccine Contract Manufacturing Global Market Report 2025 – By Service Type (Fill-Finish, Bulk Product), By Vaccine Type (Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, ...

Travel Vaccines Global Market Report 2025 – By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By Compositio...

Vaccine Adjuvants Global Market Report 2025 – By Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types), By Route of Application (Human Vaccine Adjuvants...

Conjugate Vaccine Global Market Report 2025 – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meningococcal,...

Vaccine Delivery Devices Global Market Report 2025 – By Type Of Device (Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors), By Route Of Ad...

Inactivated Vaccines Global Market Report 2025 – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation), B...

Frequently Asked Questions

What is the definition of the Live Attenuated Vaccines market?

How will the Live Attenuated Vaccines market drivers and restraints affect the market dynamics? What forces will shape the Live Attenuated Vaccines industry going forward?

The Live Attenuated Vaccines market major growth driver - The Increasing Prevalence Of Infectious Diseases Is Fueling The Growth Of The Market Due To Rising Global Incidence And Demand For Effective Long-Term Immunization. For further insights on the Live Attenuated Vaccines market, request a sample here

What is the forecast market size or the forecast market value of the Live Attenuated Vaccines market?

The Live Attenuated Vaccines market size has grown strongly in recent years. The live attenuated vaccines market size has grown rapidly in recent years. It will grow from $23.58 billion in 2024 to $25.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising global immunization coverage, increasing public health spending, growing awareness of disease prevention, rising demand for pediatric vaccines, and expansion of vaccination programs. The live attenuated vaccines market size is expected to see strong growth in the next few years. It will grow to $37.56 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising focus on preventive healthcare, increasing adoption in low- and middle-income countries, growing support for outbreak preparedness, increasing travel-related vaccination needs, and expansion of government-funded immunization initiatives. Major trends in the forecast period include advancements in vaccine delivery systems, innovations in genetic attenuation techniques, investment in research and development, development of thermostable formulations, and innovation of digital technologies in immunization programs. For further insights on the Live Attenuated Vaccines market, request a sample here

How is the Live Attenuated Vaccines market segmented?

The live attenuated vaccines market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Route Of Administration: Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated
3) By Indication: Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users

Subsegments:
1) By Monovalent: Single-Dose Vaccines, Multiple-Dose Vaccines
2) By Multivalent: Bivalent Vaccines, Trivalent Vaccines, Quadrivalent Vaccines, Other Multivalent Vaccines For further insights on the Live Attenuated Vaccines market, request a sample here

Which region has the largest share of the Live Attenuated Vaccines market? What are the other regions covered in the report?

Who are the major players in the Live Attenuated Vaccines market?

What are the key trends in the Live Attenuated Vaccines market?

Major trends in the Live Attenuated Vaccines market include Advancements In Single-Dose Live Attenuated Vaccines For Enhanced Immunization. For further insights on the Live Attenuated Vaccines market, request a sample here.